메뉴 건너뛰기




Volumn 41, Issue 5, 2014, Pages 994-999

Updating the OMERACT Filter: Core areas as a basis for defining core outcome sets

(26)  Kirwan, John R a   Boers, Maarten b   Hewlett, Sarah c   Beaton, Dorcas d   Bingham, Clifton O e   Choy, Ernest f   Conaghan, Philip G g   D'Agostino, Maria Antonietta h   Dougados, Maxime i   Furst, Daniel E j   Guillemin, Francis k   Gossec, Laure l   Van Der Heijde, Désirée M m   Kloppenburg, Margreet n   Kvien, Tore K o   Landewé, Robert B M p   Mackie, Sarah L q   Matteson, Eric L g   Mease, Philip J r   Merkel, Peter A s   more..


Author keywords

Clinical trials; Consensus development conference; Outcome and process assessment; Outcome measures in rheumatology

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CONCEPTUAL FRAMEWORK; CONSENSUS; ECONOMIC EVALUATION; HAND OSTEOARTHRITIS; HEALTH CARE; HEALTH CARE SYSTEM; HUMAN; OMERACT; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PHILOSOPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SOCIAL INTERACTION; VALIDATION PROCESS; CLINICAL TRIAL (TOPIC); CONSENSUS DEVELOPMENT; RHEUMATIC DISEASES; STANDARDS; TREATMENT OUTCOME; TRENDS;

EID: 84897387060     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.131309     Document Type: Article
Times cited : (21)

References (16)
  • 1
    • 0031990046 scopus 로고    scopus 로고
    • The OMERACT Filter for outcome measures in rheumatology
    • Boers M, Brooks P, Strand V, Tugwell P. The OMERACT Filter for outcome measures in rheumatology. J Rheumatol 1998;25:198-9.
    • (1998) J Rheumatol , vol.25 , pp. 198-199
    • Boers, M.1    Brooks, P.2    Strand, V.3    Tugwell, P.4
  • 4
    • 0027936586 scopus 로고
    • World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials
    • Boers M, Tugwell P, Felson DT, van Riel PLCM, Kirwan JR, Edmonds JP, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl. 1994 Sept;41:86-9. (Pubitemid 24285550)
    • (1994) Journal of Rheumatology , vol.21 , Issue.SUPPL. 41 , pp. 86-89
    • Boers, M.1    Tugwell, P.2    Felson, D.T.3    Van Riel, P.L.C.M.4    Kirwan, J.R.5    Edmonds, J.P.6    Smolen, J.S.7    Khaltaev, N.8    Muirden, K.D.9
  • 5
    • 26844489587 scopus 로고    scopus 로고
    • Patients' perceptions of fatigue in rheumatoid arthritis: Overwhelming, uncontrollable, ignored
    • DOI 10.1002/art.21450
    • Hewlett S, Cockshot Z, Byron M, Kitchen K, Tipler S, Pope D, et al. Patients' perceptions of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum 2005;53:697-702. (Pubitemid 41463834)
    • (2005) Arthritis Care and Research , vol.53 , Issue.5 , pp. 697-702
    • Hewlett, S.1    Cockshott, Z.2    Byron, M.3    Kitchen, K.4    Tipler, S.5    Pope, D.6    Hehir, M.7
  • 6
    • 12344329615 scopus 로고    scopus 로고
    • Rheumatology outcomes: The patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients
    • DOI 10.1093/rheumatology/keh412
    • Ahlmen M, Nordenskiold U, Archenholtz B, Thyberg I, Rönnqvist R, Lindén L, et al. Rheumatology outcomes: the patient's perspective. A multicentre focus group interview study of Swedish rheumatoid arthritis patients. Rheumatology 2005;44:105-10. (Pubitemid 40124341)
    • (2005) Rheumatology , vol.44 , Issue.1 , pp. 105-110
    • Ahlmen, M.1    Nordenskiold, U.2    Archenholtz, B.3    Thyberg, I.4    Ronnqvist, R.5    Linden, L.6    Andersson, A.-K.7    Mannerkorpi, K.8
  • 7
    • 34247637998 scopus 로고    scopus 로고
    • Measuring fatigue in rheumatoid arthritis: A systematic review of scales in use
    • Hewlett S, Hehir M, Kirwan J. Measuring fatigue in rheumatoid arthritis: a systematic review of scales in use. Arthritis Rheum 2007;57:429-539.
    • (2007) Arthritis Rheum , vol.57 , pp. 429-539
    • Hewlett, S.1    Hehir, M.2    Kirwan, J.3
  • 9
    • 84899749367 scopus 로고    scopus 로고
    • Towards a generalized framework of core measurement areas in clinical trials: A position paper for OMERACT 11
    • Boers M, Idzerda L, Kirwan JR, Beaton D, Escorpizo R, Boonen A, et al. Towards a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11. J Rheumatol 2014;41:978-85.
    • (2014) J Rheumatol , vol.41 , pp. 978-985
    • Boers, M.1    Idzerda, L.2    Kirwan, J.R.3    Beaton, D.4    Escorpizo, R.5    Boonen, A.6
  • 10
    • 84899756081 scopus 로고    scopus 로고
    • Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets
    • Idzerda L, Rader T, Tugwell P, Boers M. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets. J Rheumatol 2014;41:986-93.
    • (2014) J Rheumatol , vol.41 , pp. 986-993
    • Idzerda, L.1    Rader, T.2    Tugwell, P.3    Boers, M.4
  • 11
    • 0003758544 scopus 로고    scopus 로고
    • World Health Organization,[Internet. Accessed January 24, 2014.] Available from
    • World Health Organization. International Classification of Functioning, Disability and Health. [Internet. Accessed January 24, 2014.] Available from: www.who.int/classifications/icf/en/
    • International Classification of Functioning, Disability and Health
  • 12
    • 0003406703 scopus 로고
    • World Health Organization. Internet. Accessed December 17,2013.]World Health Organization:1990. Available from
    • World Health Organization. International Classification of Diseases (ICD-10). [Internet. Accessed December 17, 2013.] World Health Organization: 1990. Available from:
    • (1990) International Classification of Diseases (ICD-10)
  • 13
    • 0003758543 scopus 로고
    • World Health Organization [Internet. Accessed January 24,2014.] Available from
    • World Health Organization. International Classification of Impairments, Disabilities and Handicaps. Geneva, 1980. [Internet. Accessed January 24, 2014.] Available from: http://whqlibdoc.who.int/publications/1980/9241541261-eng.pdf
    • (1980) International Classification of Impairments, Disabilities and Handicaps. Geneva
  • 14
    • 84855183072 scopus 로고    scopus 로고
    • I'm hurting, i want to kill myself": Rheumatoid arthritis flare is more than a high joint count - An international patient perspective on flare where medical help is sought
    • Hewlett SE, Sanderson T, May JE, Alten R, Bingham CO 3rd, March L, et al. "I'm hurting, I want to kill myself": rheumatoid arthritis flare is more than a high joint count - an international patient perspective on flare where medical help is sought. Rheumatology 2012;51:69-76.
    • (2012) Rheumatology , vol.51 , pp. 69-76
    • Hewlett, S.E.1    Sanderson, T.2    May, J.E.3    Alten, R.4    Bingham III, C.O.5    March, L.6
  • 15
    • 84867401156 scopus 로고    scopus 로고
    • Identifying core domains to assess flare in rheumatoid arthritis: An OMERACT international patient and provider combined Delphi consensus
    • OMERACT Flare Working Group
    • Bartlett SJ, Hewlett SE, Bingham CO 3rd, Woodworth TG, Alten R, Pohl C, and the OMERACT Flare Working Group. Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensus. Ann Rheum Dis 2012;71:1855-60.
    • (2012) Ann Rheum Dis , vol.71 , pp. 1855-1860
    • Bartlett, S.J.1    Hewlett, S.E.2    Bingham III, C.O.3    Woodworth, T.G.4    Alten, R.5    Pohl, C.T.H.E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.